tiprankstipranks
Trending News
More News >
Sana Biotechnology (SANA)
NASDAQ:SANA
US Market

Compare Sana Biotechnology (SANA) vs. Competitors

Compare
836 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Sana Biotechnology
$4.58
$1.22B
-4.72
40.92%
4 Buy
0 Hold
0 Sell
Strong Buy
Geron
$1.31
$836.25M
-10.90
-55.14%
4 Buy
1 Hold
0 Sell
Strong Buy
Editas Medicine
$2.03
$198.17M
-0.85
63.71%
4 Buy
5 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$53.51
$5.10B
-9.59
32.78%
10 Buy
7 Hold
0 Sell
Moderate Buy
Taysha Gene Therapies
$4.56
$1.25B
-12.86
188.61%
10 Buy
0 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.98
$718.43M
-2.70
38.68%
4 Buy
3 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SANA
Sana Biotechnology
4.58
1.66
56.85%
GERN
Geron
1.31
-1.65
-55.74%
EDIT
Editas Medicine
2.03
0.82
67.77%
CRSP
Crispr Therapeutics AG
53.51
12.00
28.91%
TSHA
Taysha Gene Therapies
4.56
3.03
198.04%
PRME
Prime Medicine, Inc.
3.98
1.07
36.77%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts